Class A Common Stock, par value $0.0001 per share
- Symbol
- COCH
- Exchange
- NASDAQ
- Classification
- COMMON
- Status
- Current
Quarterly Report · 10-Q
Envoy Medical, Inc.
COCHNASDAQEQUITYCurrent
Quarterly Report
Company context
We are a hearing health company focused on providing innovative medical technologies across the hearing loss spectrum. Our technologies are designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they desire. Founded in 1995, our vision is to create fully implanted hearing devices that leverage the natural ear - not an artificial microphone - to pick up sound. In recent years, we have focused almost exclusively on developing the fully implanted Acclaim® cochlear implant (the “Acclaim CI”), our lead product candidate.
Current securities
Recent company filings
- Material Modification to Rights of Security Holders · Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · Regulation FD DisclosureOct 27, 2026
- Submission of Matters to a Vote of Security HoldersOct 16, 2026
- Other EventsOct 7, 2026
- DEFA14A filingSep 2, 2026
- DEF 14A filingAug 31, 2026
Registered securities in this filing
ENVOY MEDICAL, INC. · 10-Q · Filed 2026-08-10
Redeemable Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
- Symbol
- COCHW
- Exchange
- NASDAQ
- Classification
- WARRANT
- Status
- Current
As-filed source
As filedOpen full document ↗